Price CAGR:15.45%(TTM)
Over the latest trailing 12-month period, price cagr is +15.45%. The comparable SPY value is +20.96%. Year-to-date price return is +18.67%. Price CAGR uses adjusted close price history and excludes dividends.
Over longer horizons, Price CAGR averages 13.35% over 3 years and 9.73% over 5 years. The price CAGR (Compound Annual Growth Rate) shows how the company's stock price has grown over various time periods. This measures pure price appreciation without including dividends.
DGX Price CAGR Chart
Quest Diagnostics Incorporated (DGX)
DGX Quarterly Price (YoY)
Price growth vs the same quarter one year earlier, last 20 quarters.
DGX Price CAGR History
| Year | Start Price | End Price | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 150.96 | 180.46 | +29.50 | +19.54% | +19.54% |
| 2025 | 140.82 | 150.96 | +10.14 | +7.20% | +7.20% |
| 2024 | 156.79 | 140.82 | -15.97 | -10.19% | -10.19% |
| 2022 | 170.11 | 156.79 | -13.32 | -7.83% | -7.83% |
| 2021 | 118.40 | 170.11 | +51.71 | +43.67% | +43.67% |
| 2020 | 106.35 | 118.40 | +12.05 | +11.33% | +11.33% |
| 2019 | 82.01 | 106.35 | +24.34 | +29.68% | +29.68% |
| 2018 | 99.20 | 82.01 | -17.19 | -17.33% | -17.33% |
| 2017 | 92.51 | 99.20 | +6.69 | +7.23% | +7.23% |
| 2016 | 71.60 | 92.51 | +20.91 | +29.20% | +29.20% |
| 2015 | 67.78 | 71.60 | +3.82 | +5.64% | +5.64% |
| 2014 | 53.87 | 67.78 | +13.91 | +25.82% | +25.82% |
| 2013 | 58.60 | 53.87 | -4.73 | -8.07% | -8.07% |
| 2012 | 59.14 | 58.60 | -0.54 | -0.91% | -0.91% |
| 2011 | 54.54 | 59.14 | +4.60 | +8.43% | +8.43% |
| 2010 | 61.35 | 54.54 | -6.81 | -11.10% | -11.10% |
| 2009 | 49.29 | 61.35 | +12.06 | +24.47% | +24.47% |
| 2008 | 53.06 | 49.29 | -3.77 | -7.11% | -7.11% |
| 2007 | 53.07 | 53.06 | -0.01 | -0.02% | -0.02% |
| 2006 | 52.16 | 53.07 | +0.91 | +1.74% | +1.74% |
| 2005 | 47.30 | 52.16 | +4.86 | +10.27% | +10.27% |
| 2004 | 34.91 | 47.30 | +12.39 | +35.49% | +35.49% |
| 2003 | 28.65 | 34.91 | +6.26 | +21.85% | +21.85% |
| 2002 | 34.57 | 28.65 | -5.92 | -17.12% | -17.12% |
| 2001 | 31.50 | 34.57 | +3.07 | +9.75% | +9.75% |
| 2000 | 7.64 | 31.50 | +23.86 | +312.30% | +312.30% |
| 1999 | 4.42 | 7.64 | +3.22 | +72.85% | +72.85% |
| 1998 | 4.22 | 4.42 | +0.20 | +4.74% | +4.74% |
| 1997 | 3.50 | 4.22 | +0.72 | +20.57% | +20.57% |
Quarterly Price: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 206 | +5.4% | +16.0% |
| Q1 2026 | 196 | +11.5% | +17.4% |
| Q4 2025 | 175 | -7.1% | +15.8% |
| Q3 2025 | 189 | +6.2% | +21.7% |
| Q2 2025 | 178 | +6.7% | +29.5% |
| Q1 2025 | 167 | +10.0% | +25.2% |
| Q4 2024 | 152 | -2.3% | +10.8% |
| Q3 2024 | 155 | +13.0% | +24.8% |
| Q2 2024 | 137 | +3.1% | -3.0% |
| Q1 2024 | 133 | -2.7% | -0.9% |
| Q4 2023 | 137 | +10.0% | -12.8% |
| Q3 2023 | 124 | -12.1% | -0.7% |
| Q2 2023 | 141 | +5.3% | +3.7% |
| Q1 2023 | 134 | -14.3% | -6.8% |
| Q4 2022 | 157 | +25.3% | -6.5% |
| Q3 2022 | 125 | -8.3% | -18.0% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis